Life Insurance for Diabetics With Complications
Life Insurance for Diabetics With Complications
Jason Stolz CLTC, CRPC, DIA, CAA
Life insurance for diabetics with complications can feel frustrating because many companies treat “complicated diabetes” as an automatic decline — even when your real-world health picture is stable and well-managed. If you have diabetes along with complications like neuropathy, retinopathy, kidney disease, a history of DKA, or cardiovascular involvement, you may still be insurable. The outcome usually comes down to how controlled your diabetes is, how stable your complications are, which complication is present and at what severity, and which carrier is reviewing your file. At Diversified Insurance Brokers, we specialize in life insurance for impaired-risk and underwriting-heavy cases. We are an independent, family-owned, fiduciary insurance agency licensed in all 50 states, working with a large network of top-rated carriers so we can shop your case intelligently instead of guessing. Many people with diabetes complications are declined simply because their application was submitted to the wrong company, with incomplete context, or without the right strategy. Our job is to present your history clearly, choose carriers with realistic diabetic guidelines, and help you secure coverage that actually protects your family. For a broader overview of how we approach impaired-risk and complex health cases, our high-risk life insurance resource covers the foundational strategy that applies to every complex underwriting case we handle — including complicated diabetes.
Life Insurance for Diabetics With Complications
Diabetes complications don’t automatically disqualify you from life insurance. We help you shop the right carriers, structure the right policy, and secure coverage that fits your real medical picture.
Request Information Call 800-533-5969Life Insurance Quoter
Use the quoter below to get an instant baseline estimate for coverage amounts and term lengths. For diabetics with complications, we then match your specific complication profile and control history to carriers with the most favorable underwriting guidelines for your situation.
See Real-Term Rates Side by Side
Diabetic Complications — Underwriting Profile by Complication Type
Life insurance underwriters do not evaluate “diabetes with complications” as a single risk category. They evaluate each specific complication type, its severity and documented stability, and how it interacts with the overall diabetic control picture. The table below maps each major complication category to what carriers typically examine and how different clinical presentations affect underwriting outcomes.
General reference only. Actual outcomes depend on full clinical history, A1C trends, specific carrier guidelines, documentation quality, and the combination of complications present. Individual results vary significantly.
| Complication Type | What Carriers Evaluate | What Strengthens the File | Typical Underwriting Impact |
|---|---|---|---|
| Peripheral Neuropathy | Symptom severity (mild tingling vs. significant functional impairment); medication requirements; foot care history; stability trend over time | Mild stable symptoms; no foot ulcers or infections; limited medication needs; neurologist or podiatrist follow-up confirming stability; no amputations | Mild neuropathy: moderate table ratings often achievable at appropriate carriers. Severe impairment with foot complications: significantly higher ratings or declination; simplified issue most realistic |
| Diabetic Retinopathy | Stage (non-proliferative vs. proliferative); progression rate; ophthalmology follow-up frequency; laser treatment or injection history; any vision impairment | Non-proliferative, mild stage with routine monitoring; no active treatment needed; stable findings across multiple ophthalmology visits; no vision loss documented | Background/mild NPDR: table ratings common, coverage often achievable. Proliferative or vision-threatening: higher ratings, face amount limits; simplified issue may be more realistic |
| Diabetic Nephropathy / CKD | eGFR trend over multiple readings; creatinine stability; micro vs. macroalbuminuria; nephrology involvement; blood pressure control (heavily weighted); CKD stage if documented | Stable eGFR above 60 with no declining trend; microalbuminuria only (not macroalbuminuria); nephrology or PCP notes confirming stability; controlled blood pressure on stable regimen | Single most impactful complication in diabetic underwriting. Early/stable microalbuminuria: moderate ratings possible. CKD Stage 3+: heavy ratings or declination. Dialysis or transplant: simplified/guaranteed issue only |
| Cardiovascular Disease (CAD, Stents, MI, TIA/Stroke) | Event type, date, and recency; current symptoms; medications and compliance; cardiology follow-up; blood pressure and cholesterol control; EF or imaging results if available | Event well in the past (2+ years); asymptomatic since; cardiology-confirmed stable function; blood pressure and lipids well-controlled; no repeat events; revascularization successful with stable post-procedure status | Combines diabetic and cardiovascular risk frameworks — compounded underwriting. Older stable event with good control: higher table ratings at specialty carriers. Recent event or significant findings: likely decline or simplified issue only |
| DKA History | When the event occurred; whether it was isolated or recurrent; precipitating cause; changes made since (CGM adoption, insulin regimen, education); time elapsed | Single isolated event years in the past; clear cause identified and addressed; no repeat episodes; documented management improvements (CGM, structured education, regimen change); stable A1C since | Isolated, old, with documented improvement: moderate table ratings possible. Recent or recurrent DKA: significant ratings or postponement; carriers want 12-24 months of stability post-event |
| Diabetic Foot Complications (Ulcers, Infections) | History of foot ulcers, cellulitis, osteomyelitis; whether fully healed; podiatry follow-up; amputation history (partial digit vs. limb-level); recurrence pattern | Fully healed, single episode, no recurrence; regular podiatry follow-up documented; improved glycemic control since episode; wound care protocols in place | Even a single ulcer history raises scrutiny significantly. Fully healed with good control: higher ratings. Amputation history or recurrent infections: typically limits to simplified or guaranteed issue coverage |
| Autonomic Neuropathy / Gastroparesis | Severity of autonomic dysfunction; cardiac autonomic neuropathy presence; gastroparesis diagnosis and management; symptoms (orthostatic hypotension, bladder dysfunction); hospitalization history | Mild, well-managed autonomic symptoms; gastric emptying study showing mild delay; managed with diet and medication without frequent hospitalizations; stable symptoms over time | One of the more restrictive complication categories — autonomic neuropathy signals systemic disease progression. Cardiac autonomic neuropathy is a serious underwriting concern; most cases require specialty carriers and produce heavy ratings or declination |
Can You Get Life Insurance With Diabetes Complications?
Yes — many people with diabetes complications can still qualify for life insurance. The key is that underwriters do not rate “diabetes” as one single box. They rate your overall risk profile and the probability of future complications over the life of the policy. Two applicants can both be diabetic and both have a complication listed in their chart, yet end up with very different results depending on a constellation of factors. A1C history and trend are evaluated as a pattern rather than a snapshot — stable or improving A1C results paired with consistent follow-up care produce meaningfully better outcomes than a single favorable reading without supporting documentation. The medication plan and documented compliance signal to underwriters whether the disease is being actively and consistently managed. Complication severity distinguishes mild, early-stage findings from advanced disease with organ involvement. Specialist follow-up through endocrinology, ophthalmology, nephrology, and cardiology gives underwriters confidence that the condition is being proactively monitored. Blood pressure and lipid control are major risk swing factors — for diabetics, these are often weighted as heavily as A1C in the overall underwriting picture. Tobacco use or recent nicotine exposure pushes many carriers into more aggressive rating categories even when diabetes is otherwise well-managed. Any hospitalizations related to DKA, hypoglycemia, infections, or cardiac events are closely scrutinized for recency and pattern. That is why working with an agency that understands impaired-risk underwriting matters. We do not “throw your application at one carrier and hope” — we build a plan based on your profile and your most likely underwriting lane, especially when complications are involved.
What Underwriters Actually Measure — The Diabetic Control Framework
The table below covers the specific metrics that underwriters evaluate as the foundation of any diabetic life insurance file — the control framework that sits underneath the specific complication assessment.
| Control Factor | Why It Matters in Underwriting | Favorable Signal | Unfavorable Signal |
|---|---|---|---|
| A1C Trend (Not One Reading) | Underwriters prefer a pattern over a snapshot — multiple A1C readings across 12-24 months showing direction and consistency of glycemic control | A1C in the 6.5-8.0% range across multiple readings; stable or improving trend; no single dramatically elevated reading surrounded by otherwise favorable values | A1C consistently above 9-10%; significant variability between readings suggesting inconsistent control; worsening trend over time; single favorable reading without trend context |
| Kidney Labs (eGFR, Creatinine, Urine Protein) | Kidney function is the single most impactful lab category in diabetic underwriting — even early findings change pricing significantly | eGFR above 60 and stable; creatinine within normal range; microalbuminuria only (not macroalbuminuria); no declining trend across multiple readings over 12-24 months | Declining eGFR trend; macroalbuminuria or significant proteinuria; creatinine above normal range; CKD Stage 3 or higher documented; nephrology noting progressive disease |
| Blood Pressure and Lipid Control | For diabetics, cardiovascular risk factors are evaluated as part of the total diabetic risk — not separately; BP and lipid control can be the difference between a moderate and heavy rating | Blood pressure consistently below 140/90 on stable medication; LDL well-controlled; statin therapy compliance documented; no recent significant changes to cardiovascular medication regimen | Consistently elevated blood pressure despite treatment; poorly controlled lipids; multiple recent medication adjustments suggesting instability; hypertension with documented target organ damage |
| Hospitalization History | Recency and frequency of hospital admissions related to diabetes or its complications — recent instability raises mortality assumptions substantially regardless of current status | No hospitalization in 2+ years for any diabetic complication; any past hospitalizations well in the past with documented stability since; no pattern of recurrent admissions | Any hospitalization within 12 months for diabetic complications; recurrent admissions suggesting poorly controlled disease; ICU admissions for DKA, cardiac events, or infections |
| Specialist Follow-Up Documentation | Whether regular specialist care is occurring and documented — endocrinology, ophthalmology, nephrology, podiatry, cardiology notes provide the stability narrative underwriters need | Regular endocrinology visits; ophthalmology annual exams documented; nephrology involved when kidney labs indicate; specialist notes explicitly confirming stability and follow-up plan | PCP-only management of complex diabetes without specialist involvement; gaps in specialist care; sparse or vague notes without specific stability assessments; no ophthalmology or podiatry record despite complications |
Type 1 vs. Type 2 Diabetes With Complications — Does the Distinction Matter?
Both Type 1 and Type 2 diabetes with complications are underwritten based primarily on the specific complications present and the overall control picture — but there are meaningful differences in how carriers approach the two diagnoses that affect application strategy. Type 1 diabetes with complications creates a more complex underwriting picture because the autoimmune origin and typically longer disease duration mean complications may be more advanced by the time an applicant is seeking coverage. DKA history is more common in Type 1 files, and carriers who are less experienced with Type 1 underwriting sometimes apply guidelines designed for Type 2 that do not accurately reflect the actual risk profile of a well-managed Type 1 patient. Type 2 diabetes with complications — while representing a larger patient population — often presents with cardiovascular and metabolic comorbidities (hypertension, obesity, dyslipidemia) that compound the underwriting picture beyond the diabetic complications alone. The underwriting approach for T2D complications frequently requires evaluation of the metabolic syndrome components alongside the specific organ involvement. For applicants who want the foundational underwriting context for Type 2 diabetes without complications, our resource on life insurance for Type 2 diabetes covers the standard evaluation framework — and the complicated diabetes page you are reading now addresses the additional considerations that apply when complications are present. Most COPD patients, Type 2 diabetics, and applicants with cardiovascular disease share overlapping demographic profiles — our resource on life insurance for COPD covers the respiratory complication dimension that frequently accompanies advanced Type 2 diabetes in older applicants.
Why Diabetic Complications Change the Underwriting Conversation
Most life insurance companies are comfortable underwriting uncomplicated diabetes when it is well-controlled. The difference with complications is that they can signal long-term disease progression. The underwriter’s job is to determine whether the complication is mild and stable — meaning the applicant may still qualify for traditional term or permanent coverage — or advanced or worsening — meaning pricing will be higher, coverage may be limited, or alternative products become more realistic. The good news is that complications are not always a deal-breaker. Many people live with mild neuropathy, early-stage retinopathy, or minor kidney findings for years without significant progression. When that stability is documented and clearly presented, carriers often respond much better than people expect. Our resource on life insurance alternatives covers the options that make sense when traditional underwriting is not available, and our resource on what life insurance does not cover — our page on what deaths are not covered — clarifies the policy exclusion framework that applies regardless of how a policy is issued.
The Kidney Complication — Why It Drives More Outcomes Than Any Other
Among all diabetic complications, kidney involvement consistently carries the most underwriting weight — because the progression from microalbuminuria to macroalbuminuria to established CKD to dialysis or transplant represents one of the most predictable and actuarially well-documented risk trajectories in impaired-risk life insurance. Underwriters treat any kidney finding in a diabetic file with heightened scrutiny, and the specific laboratory values are reviewed not just for their current level but for their trend over multiple readings across 12 to 24 months. Stable microalbuminuria — early leakage of albumin into urine — with well-controlled blood pressure and an eGFR above 60 that has remained stable over time represents the most favorable kidney complication profile and can still qualify for traditional underwriting at appropriate carriers, often with moderate table ratings rather than declination. Macroalbuminuria, declining eGFR below 45-60, or CKD Stage 3 or higher substantially changes the pricing and eligibility picture. At CKD Stage 4-5 or with documented dialysis, traditional underwriting becomes unavailable at virtually all carriers, and the realistic pathway shifts to simplified issue or guaranteed issue coverage. Our dedicated resource on life insurance for kidney disease covers the eGFR staging framework, how multiple readings create trend context, and which carriers have historically been most favorable for kidney-involved diabetic files. For diabetic patients who have progressed to kidney failure and transplant, our resource on life insurance for organ transplant recipients covers the post-transplant underwriting framework that applies — a separate evaluation path from the kidney disease framework, with its own stability window requirements and documentation standards.
Cardiovascular Complications — How the Combined Risk Profile Is Evaluated
Diabetes and cardiovascular disease are so closely linked in actuarial tables that many carriers effectively evaluate any diabetic file through a cardiovascular lens whether or not a cardiac event has occurred. When there is documented cardiovascular history — coronary artery disease, stent placement, myocardial infarction, TIA, or stroke — the underwriting evaluation becomes a compounded assessment of both the diabetic risk framework and the cardiovascular risk framework, producing a total mortality assumption more conservative than either condition would generate alone. This compounded evaluation is one of the primary reasons why complicated diabetes with cardiovascular history requires specialty carrier access rather than standard market placement. For the cardiovascular underwriting framework that applies when diabetic heart disease is documented, our resource on life insurance after a cardiac event covers the key metrics that are evaluated — event timing, revascularization success, current ejection fraction, and symptom status — all of which underwriters review alongside the diabetic control picture. For diabetics who have developed stroke as a cardiovascular complication, our resource on life insurance after stroke covers the neurological outcome assessment that compounds the diabetic underwriting evaluation when stroke is part of the history. Diabetic cardiomyopathy — direct myocardial damage from chronic hyperglycemia — is a specific and underwriting-significant diagnosis that appears in advanced diabetic files and is evaluated through a specialized framework covered in our resource on life insurance for cardiomyopathy.
DKA History — How Timing and Pattern Change Everything
A past DKA (diabetic ketoacidosis) admission or severe low-blood-sugar event does not automatically mean a decline, but it raises underwriting scrutiny because both events signal periods of inadequate metabolic control — and underwriters want to understand whether the circumstances were isolated or represent a recurring pattern. For DKA specifically, carriers typically want to know when the event occurred and whether it was truly isolated, what caused it (an intercurrent illness, missed insulin, medication adjustment, or poor baseline control), whether there have been repeat events in the years since, and what has changed since to improve stability. Isolated DKA that occurred several years ago, where the record clearly shows a precipitating cause, no recurrence, and improved management since — often including CGM adoption or structured diabetes education — can still qualify for traditional underwriting with appropriate table ratings. Recurrent DKA, recent DKA, or a pattern suggesting chronically poor control typically triggers postponement at most carriers and requires a documented stable window before reapplication will be considered. The key distinction in DKA underwriting is between “an acute event in an otherwise controlled patient” and “evidence of persistently uncontrolled diabetes.” For Type 1 patients specifically, isolated DKA in the context of an acute illness is viewed differently from DKA arising from baseline poor control — and that distinction requires clear documentation and an advisor who can present the clinical narrative accurately.
What Improves Your Approval Odds Even With Complications
If you have complicated diabetes, you do not need “perfect health” to qualify. What you need is a clear, stable underwriting story supported by documentation that reduces the uncertainty that drives conservative pricing. Trend data matters more than any single result — underwriters prefer patterns over snapshots. A stable A1C trend, stable kidney labs, and consistent follow-up notes tell a much stronger story than one isolated favorable reading surrounded by undocumented periods. Specialist follow-up through endocrinology, ophthalmology, and nephrology gives carriers confidence that your condition is being managed proactively — and specialist notes that explicitly confirm stability provide much more useful underwriting context than vague PCP notes that simply list medications. Controlled blood pressure and lipids can be the difference between a moderate rating and a hard decline for diabetics — underwriters look at the full cardiovascular risk picture alongside glucose control, not just the A1C in isolation. Tobacco-free status matters more than many applicants realize — nicotine exposure can drastically increase pricing and reduce carrier flexibility even when diabetes is otherwise well-managed. Clear documentation of stability is the overarching goal: many complicated diabetes cases receive harsh ratings not because of the actual clinical picture but because the file looks unclear, incomplete, or inconsistent. Many of these factors — and the prescreening strategy that identifies the right carrier before formal application — are covered in the foundational underwriting resource that applies to all complex health profiles. For over-50 applicants managing diabetes complications alongside the natural health changes that come with age, our resource on life insurance over 50 covers how the age-related underwriting context intersects with chronic condition evaluation for the demographic where complicated Type 2 diabetes most commonly presents. For applicants who use cannabis therapeutically and want to understand how that interacts with diabetic underwriting at the tobacco-status level, our resource on whether marijuana use affects life insurance rate classes covers the specific carrier-by-carrier variation in how cannabis is classified alongside tobacco history.
Best Policy Types for Diabetics With Complications
There is not one “best” policy for complicated diabetes — the right solution depends on your age, coverage goal, budget, and expected underwriting result. In most cases we compare several pathways. Traditional term life insurance for 10 to 30 years is often the best value for income replacement, mortgages, and protecting young families. With diabetes complications, term is still possible for many applicants — but underwriting becomes more detail-driven, and table ratings are more common than preferred pricing. Permanent life insurance including whole life or universal life can be a strong fit when you need lifetime protection for final expenses, legacy planning, or leaving money behind for family. If underwriting is challenging, a smaller permanent policy can sometimes be easier to secure than a large term amount. Simplified issue policies reduce the exam and lab burden and can deliver faster decisions — these work well when your medical file is stable but you want less underwriting friction or a faster path. Guaranteed issue life insurance can be a safety net when there have been repeated declines or when complications are advanced. These policies typically have smaller face amounts and graded benefits during the first two to three years, but they can still solve the problem of getting protection in place when it is needed. Our resource on guaranteed issue burial insurance covers how graded benefit structures work, what face amounts are realistic, and when this pathway makes the most sense relative to other options. For applicants who want a no-exam pathway specifically, our resource on no-exam life insurance covers the simplified underwriting programs that can bypass the paramed exam for qualifying applicants — including some diabetics with stable profiles who prefer a faster, less involved application process.
Understanding how table ratings translate into actual premium cost is essential for any diabetic with complications who receives a rated offer. Our resource on what is a flat extra in life insurance covers both the table rating mechanism and the flat extra surcharge that some carriers use for diabetic complications, including how to calculate the total dollar cost of a rated offer. For context on how annuity income can help fund life insurance premiums without creating household budget strain — particularly useful for over-50 diabetics who may have reduced earned income alongside life insurance obligations — our resource on how annuity payments can fund life insurance premiums covers the integration approach that many retirees with chronic conditions use to maintain coverage.
Coverage Strategy — Sizing, Layering, and Planning for Improvement
For complicated diabetes, coverage strategy matters as much as product selection. Some people aim for one large policy immediately, while others do better with a layered approach. A common starting point is replacing income, covering major debts, and keeping the family stable if the unexpected happens — starting with that core amount rather than trying to maximize the face amount and potentially triggering a decline on the full application. Many families use a layered strategy: secure a strong foundational amount now at current underwriting conditions, then add more coverage later once stability is further documented or if underwriting improves as health metrics strengthen. This reduces the risk of overreaching on a first application and getting declined for the full amount — which creates MIB history that can complicate subsequent placements. For a simple starting estimate of coverage needs before talking with an advisor, our life insurance calculator can help ballpark an amount based on income, debts, and family needs.
What If You Have Been Declined Before?
A prior decline does not mean you are uninsurable. It usually means the case was submitted in a way that did not fit that carrier’s diabetic guidelines — wrong carrier selection, incomplete documentation, or context that was unclear enough to trigger conservative underwriting assumptions. Some insurers are strict on retinopathy findings, some apply heavy ratings to any kidney involvement, and some penalize neuropathy more aggressively than others. When someone comes to us after a decline, our goal is to understand specifically why the decline happened and which part of the file was the trigger; identify whether the trigger was a documentation gap, a carrier mismatch, or a genuine underwriting barrier; restructure the submission with the right medical context and targeted documentation; and identify carriers that underwrite that specific complication more reasonably. In many cases we also consider a pre-screen approach before any formal application is submitted — summarizing the key medical facts informally for carriers to review before an MIB record is created. That strategy can prevent unnecessary declines and improves the chance of a clean approval path. For a deeper understanding of the prescreening process that protects applicants from avoidable declines, this strategy is covered in detail in our resource on how to prescreen a life insurance application.
Get Help With Diabetic Life Insurance — Complications Included
We’ll review your history, shop carriers that underwrite complications fairly, and help you secure coverage that actually fits your situation.
Request Information Call 800-533-5969Related Life Insurance and Underwriting Pages
Underwriting strategy, table ratings, prescreening, and high-risk carrier resources for complex diabetic cases.
Related Planning and Coverage Strategy Pages
Coverage planning, policy structure, and core diabetes life insurance resources.
Financial Protection Essentials
Life insurance resources for parallel complex conditions with underwriting approaches that share meaningful overlap with complicated diabetes.
Compare Term Life Insurance Lengths
Explore different term periods to find coverage that best matches your timeline and budget.
Talk With an Advisor Today
Choose how you’d like to connect—call or message us, then book a time that works for you.
Schedule here:
calendly.com/jason-dibcompanies/diversified-quotes
Licensed in all 50 states • Fiduciary, family-owned since 1980
FAQs: Life Insurance for Diabetics With Complications
Can I get life insurance if I have diabetes complications?
Yes — many diabetics with complications can still qualify for life insurance. Approval depends on your overall glycemic control, stability of the specific complication, A1C history and trend, kidney labs, blood pressure and lipid management, specialist follow-up documentation, and which carriers we shop your case with. The same applicant can receive a meaningful offer at one carrier and a decline at another based entirely on carrier-specific guidelines for the complication you have. Mild, stable complications with well-documented management history often qualify for traditional term or permanent coverage at appropriate table ratings. Advanced or poorly controlled complications narrow the realistic pathway to simplified issue or guaranteed issue options, but even in those scenarios meaningful protection is often achievable.
What diabetes complications impact underwriting the most?
Kidney involvement — including microalbuminuria, macroalbuminuria, or documented CKD staging — consistently has the largest single impact on diabetic life insurance underwriting. Even early kidney findings change pricing materially, and advanced kidney disease shifts the realistic pathway away from traditional underwriting entirely. Cardiovascular complications including coronary artery disease, stent placement, MI, TIA, or stroke compound the underwriting picture significantly because both diabetic and cardiovascular risk frameworks apply simultaneously. Retinopathy is evaluated by stage — early non-proliferative findings are manageable, while proliferative or vision-threatening retinopathy raises substantial concerns. Neuropathy with foot complications including ulcers, infections, or amputations is among the most restrictive findings. DKA history, autonomic neuropathy, and gastroparesis also trigger heightened scrutiny.
Will a high A1C automatically get me declined?
No — underwriters look at trends over time, not just one reading. A consistently elevated A1C across multiple readings over 12-24 months raises much more concern than a single elevated value surrounded by otherwise stable results. Stable or improving A1C trends paired with consistent specialist follow-up care usually improve outcomes meaningfully, even when the absolute A1C value is higher than the optimal range. The story the trend tells matters more than any single number. That said, A1C consistently above 9-10% with no improving trend — especially when combined with complications — significantly limits coverage options and produces more conservative outcomes at most carriers.
Do I have to take a medical exam for diabetic life insurance?
Not always. Fully underwritten policies — which typically offer the largest face amounts at the most competitive pricing for qualifying applicants — usually include a paramed exam, blood draw, and medical records review. Simplified issue policies rely on health questions only without an exam, offer faster decisions, and can work well when the clinical picture is stable but you prefer less underwriting friction. Guaranteed issue policies require no exam and no health questions at all, with coverage guaranteed for eligible age ranges. For diabetics with complications, the pathway depends on how complex the clinical picture is — mild, stable complications may qualify for accelerated underwriting with limited or no exam at some carriers, while complex files typically require full underwriting with specialist records.
Can I qualify for life insurance if I use insulin?
Yes — insulin use does not automatically prevent approval. The bigger factors are overall glycemic control, the stability and adequacy of the insulin regimen, whether the regimen has been stable over time, and whether complications are mild, moderate, or advanced. Insulin-dependent diabetics with well-controlled A1C, stable complications, and consistent specialist follow-up qualify for coverage regularly — the insulin itself is not the barrier. What underwriters evaluate is whether the insulin regimen is producing controlled outcomes or whether the diabetes is still poorly managed despite insulin therapy. Type 1 diabetics on insulin are evaluated somewhat differently than Type 2 diabetics who have been escalated to insulin — the reason for insulin use, duration, and dose trends all provide clinical context.
What if I’ve had DKA in the past?
Coverage may still be possible, but underwriting will focus on what caused the event, how long ago it occurred, whether there have been repeat episodes, and what has changed since then to improve stability and prevent recurrence. An isolated DKA event years in the past — where the precipitating cause was clearly identified (intercurrent illness, missed insulin dose, medication adjustment), no repeat episodes have occurred, and documented management improvements have been made since — can still qualify for traditional underwriting with table ratings at appropriate carriers. Recent DKA (within the past 12 months) or a pattern of recurrent episodes typically triggers postponement at most carriers, who want to see a meaningful stable window after the last event before reviewing the case favorably.
How does kidney disease from diabetes affect life insurance eligibility?
Kidney complications often have the largest individual impact on pricing and eligibility in any diabetic life insurance file. Underwriters commonly evaluate eGFR trend over multiple readings across 12-24 months (not just the most recent value), creatinine stability, urine protein results including whether microalbuminuria has progressed to macroalbuminuria, whether nephrology is involved, and whether blood pressure is well-controlled. Stable microalbuminuria with eGFR above 60 and controlled blood pressure often still qualifies for traditional underwriting at appropriate table ratings. Declining eGFR below 45-60, macroalbuminuria, or CKD Stage 3 or higher substantially narrows options and increases the likelihood of simplified issue as the more realistic pathway. Dialysis or kidney transplant effectively closes traditional underwriting at virtually all standard carriers.
What coverage options exist if traditional underwriting isn’t available?
When fully underwritten coverage does not fit the situation today, there are still meaningful options. Simplified issue policies use health questions without a medical exam and can provide face amounts typically ranging from $25,000 to $100,000 or more depending on the carrier and your specific answers — with faster approval timelines than traditional underwriting. Guaranteed issue whole life policies require no health questions and guarantee approval within the eligible age range, typically with face amounts from $5,000 to $25,000 and a graded benefit period during the first two to three years. Even smaller guaranteed issue coverage can solve the immediate problem of getting protection in place while we continue exploring whether better traditional options become available as health metrics stabilize and improve. A layered strategy — securing what is available now and adding more later — is often more practical than waiting for a perfect underwriting window that may not materialize.
How much life insurance should I consider with diabetic complications?
Coverage need depends on your income, outstanding debts, family financial obligations, and goals. Most families start with coverage sufficient to replace the primary earner’s income for a defined period (5-10 years), pay off the mortgage, and maintain household stability during the most financially vulnerable transition period. For complex diabetic cases, a realistic starting point is the amount needed to fulfill those core obligations at the underwriting outcome that is actually achievable — rather than starting with a desired face amount and discovering it is not available through traditional underwriting. The layered approach works well: secure a foundational amount now under current underwriting conditions, then revisit and add more coverage once the stability window is longer, A1C trends are more consistently favorable, and kidney or other labs show continued stability. This avoids the frustration of applying for too much and receiving either a decline or an offer that doesn’t meet the coverage need.
Can my pricing improve in the future as my health stabilizes?
Yes — better stability, improved A1C trends, sustained blood pressure and lipid control, and a longer gap since the most recent complication event or hospitalization can all support better offers at future underwriting reviews. Many carriers will consider re-underwriting an in-force policy if health has materially improved since the original issuance — a process called “rate improvement” that some carriers offer formally and others evaluate case-by-case. Additionally, as an existing policy builds its stability record, reapplying for additional coverage at a new underwriting review with updated favorable records can produce better results than the original application. We track these opportunities with clients and proactively identify when a re-shop or a new application is likely to produce meaningfully different results than the current coverage structure.
Why do some carriers treat diabetic complications so much more harshly than others?
Each insurance carrier uses its own actuarial models, internal claims experience databases, and underwriting philosophy for diabetic complications. Carriers with limited claims history for specific complication types — nephropathy, proliferative retinopathy, autonomic neuropathy — tend to apply conservative blanket guidelines rather than granular evaluation of severity and stability. Carriers with deeper diabetic underwriting experience have more refined models that distinguish mild stable complications from advanced progressive disease, and price each tier more accurately. The practical implication is significant: applying to the wrong carrier first produces a decline or a prohibitively expensive offer for a profile that another carrier would approve at a reasonable table rating. This carrier variation is why independent broker access to multiple carriers — rather than a single company’s internal guidelines — consistently produces better outcomes for complicated diabetic cases.
What should I gather before requesting a diabetic complications life insurance quote?
The most useful information to have ready includes your diabetes type (Type 1 or Type 2), diagnosis date, most recent A1C and the date tested, a summary of the last 2-3 A1C readings showing the trend, current medication list (all medications, not just diabetes-related), specific complications documented and their approximate diagnosis dates, most recent kidney labs including eGFR and creatinine values with dates, blood pressure readings at last visit, specialist names and their specialties, any hospitalization history related to diabetes including dates and causes, and tobacco status with cessation date if applicable. The more complete and current this information is, the more accurately we can identify which carriers are most likely to evaluate your profile favorably and structure the inquiry or application most effectively before any formal submission.
About the Author:
Jason Stolz, CLTC, CRPC, DIA, CAA and Chief Underwriter at Diversified Insurance Brokers (NPN 20471358), is a senior insurance and retirement professional with more than 25 years of real-world experience helping individuals, families, and business owners protect their income, assets, and long-term financial stability. As a long-time partner of the nationally licensed independent agency Diversified Insurance Brokers, Jason provides trusted guidance across multiple specialties—including fixed and indexed annuities, long-term care planning, personal and business disability insurance, life insurance solutions, Group Health, Travel Medical and Evacuation Insurance, and short-term health coverage. Diversified Insurance Brokers maintains active contracts with over 100 highly rated insurance carriers, ensuring clients have access to a broad and competitive marketplace.
His practical, education-first approach has earned recognition in publications such as VoyageATL, and contributions from his agency featured in Kiplinger and GoBankingRates— highlighting his commitment to financial clarity and client-focused planning. Drawing on deep product knowledge and years of hands-on field experience, Jason helps clients evaluate carriers, compare strategies, and build retirement and protection plans that are both secure and cost-efficient. Visitors who want to explore current annuity rates and compare options across multiple insurers can also use this annuity quote and comparison tool.
Explore More Life Insurance Options: Browse our complete guide to High Risk Life Insurance — covering health conditions, guaranteed issue, special needs & underwriting challenges from 100+ carriers.
Last Reviewed: May 30, 2026 |
Reviewed by: Jason Stolz, CLTC, CRPC, DIA, CAA
Chief Underwriter, Diversified Insurance Brokers, Inc. | NPN: 20471358 | Diversified Insurance Brokers, Inc. — Licensed in all 50 states
Fact Checked by: Tonia Pettitt, CMIP©
Medicare Specialist, Diversified Insurance Brokers, Inc. | NPN: 14374308 | Diversified Insurance Brokers, Inc. — Licensed in all 50 states
Editorial Standards: Diversified Insurance Brokers maintains rigorous editorial standards to ensure accuracy, clarity, and independence in all content. Learn more about our editorial standards and commitment to transparency.
